Corrado Ameli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Corrado Ameli has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Skupin
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg
2 shared publications - Andreas Daiber
University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany
2 shared publications - David S. Bouvier
National Center of Pathology (NCP), Laboratoire National de Santé (LNS), Dudelange, Luxembourg
2 shared publications - Marin Kuntic
Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany
2 shared publications - Petr V. Nazarov
Department of Cancer Research, Luxembourg Institute of Health, Luxembourg
2 shared publications - Sonja Fixemer
University of Luxembourg
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1462
Phagocytic NADPH Oxidase (NOX-2) as a Central Oxidative Effector in Experimental Models of Transportation-Noise-Induced Cardiovascular and Cerebral Disease
Transportation noise is an established cardiovascular risk factor. More than 112 million Europeans are chronically exposed above the thresholds of the Environmental Noise Directive, with approximately 73,000 premature deaths and 1.5 million disability-adjusted life years attributed annually. Large cohort studies demonstrate near-linear exposure–response relationships with ischaemic heart disease, myocardial infarction, stroke, heart failure and type 2 diabetes, and more recently with dementia, Alzheimer’s disease and Parkinson disease, independent of air pollution, detectable below guideline limits and stronger for night-time exposure. The noise reaction model attributes these effects to annoyance, sleep fragmentation and activation of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis, converging on oxidative stress, inflammation and endothelial dysfunction. This review argues that the phagocytic NADPH oxidase NOX-2 (gp91phox) is a decisive oxidative effector within that cascade in experimental models of noise exposure. NOX-2 is upregulated in the vasculature and brain after aircraft noise exposure, is delivered to the vessel wall largely by infiltrating myelomonocytic cells, and drives superoxide formation, peroxynitrite generation, and uncoupling of endothelial and neuronal nitric oxide synthase. Genetic deletion of Nox2 prevents, essentially, the entire vascular phenotype and attenuates cerebral oxidative stress and neuroinflammation, whereas ablation of lysozyme M-positive myeloid cells reproduces the vascular but not cerebral protection. These causal data derive predominantly from short-term rodent aircraft-noise models and require further extrapolation in chronic human exposure settings. In line with this proposed mechanism of action, noise-mediated organ damage can be mitigated by pharmacological and lifestyle-associated anti-oxidant interventions that are also briefly summarised here.
- 10 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1462
Open AccessPhagocytic NADPH Oxidase (NOX-2) as a Central Oxidative Effector in Experimental Models of Transportation-Noise-Induced Cardiovascular and Cerebral Disease
Transportation noise is an established cardiovascular risk factor. More than 112 million Europeans are chronically exposed above the thresholds of the Environmental Noise Directive, with approximately 73,000 premature deaths and 1.5 million disability-adjusted life years attributed annually. Large cohort studies demonstrate near-linear exposure–response relationships with ischaemic heart disease, myocardial infarction, stroke, heart failure and type 2 diabetes, and more recently with dementia, Alzheimer’s disease and Parkinson disease, independent of air pollution, detectable below guideline limits and stronger for night-time exposure. The noise reaction model attributes these effects to annoyance, sleep fragmentation and activation of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis, converging on oxidative stress, inflammation and endothelial dysfunction. This review argues that the phagocytic NADPH oxidase NOX-2 (gp91phox) is a decisive oxidative effector within that cascade in experimental models of noise exposure. NOX-2 is upregulated in the vasculature and brain after aircraft noise exposure, is delivered to the vessel wall largely by infiltrating myelomonocytic cells, and drives superoxide formation, peroxynitrite generation, and uncoupling of endothelial and neuronal nitric oxide synthase. Genetic deletion of Nox2 prevents, essentially, the entire vascular phenotype and attenuates cerebral oxidative stress and neuroinflammation, whereas ablation of lysozyme M-positive myeloid cells reproduces the vascular but not cerebral protection. These causal data derive predominantly from short-term rodent aircraft-noise models and require further extrapolation in chronic human exposure settings. In line with this proposed mechanism of action, noise-mediated organ damage can be mitigated by pharmacological and lifestyle-associated anti-oxidant interventions that are also briefly summarised here.
- Open Access
- 24 September 2026
- Published by Elsevier in Environmental Pollution
- Vol. 410
Acute co-exposure to urban particulate matter and aircraft noise elicits lung-centered immune-redox proteomic remodeling in mice
- 24 September 2026
- Published by Elsevier in Environmental Pollution
- Vol. 410
Open AccessAcute co-exposure to urban particulate matter and aircraft noise elicits lung-centered immune-redox proteomic remodeling in mice
- Open Access
- 24 August 2022
- Published by Springer Nature in SN Computer Science
- Vol. 3 (6) , 1-11
PaFSe: A Parameter-Free Segmentation Approach for 3D Fluorescent Images
Confocal fluorescent microscopy is a major tool to investigate the molecular orchestration of biomedical samples. The quality of the image acquisition depends critically on the tissue quality and thickness, the type, and concentration of antibodies used, as well as on microscope parameters. Due to these factors, intra-sample and inter-sample variability inevitably arises. Segmentation and quantification of targeted proteins can thus become a challenging process. Image processing techniques need therefore to address the acquisitions variability to minimize the risk of biases originating from changes in signal intensity, background noise, and parameterization. Here, we introduce PaFSe, a parameter-free segmentation algorithm for 3D fluorescent images. The algorithm is based on our established PRAQA approach, which evaluates the dispersion of several pixel intensity neighborhoods allowing for a statistical assessment whether individual subfields of an image can be considered as positive signal or background. PaFSe extends PRAQA by a fully automatic estimate for the segmentation parameters, and thereby provides a completely parameter-free and robust segmentation algorithm. By comparing PaFSe with Ilastik on synthetic examples, we show that our method achieves similar performances as a supervised approach in low-to-moderate noise environments without the need of tedious training. Furthermore, we validate the efficiency of PaFSe by segmenting and quantifying the abundance of hyperphosphorylated Tau protein in post-mortem human brain samples from Alzheimer’s disease patients and age-matched controls, where we obtain quantification values highly correlated with manual neuropathological segmentation. PaFSe is a parameter-free, fast, and adaptive approach for robust segmentation and quantification of protein abundance from complex 3D fluorescent images and is freely available at https://doi.org/10.17881/j20h-pa27.
- 24 August 2022
- Published by Springer Nature in SN Computer Science
- Vol. 3 (6) , 1-11
Open AccessPaFSe: A Parameter-Free Segmentation Approach for 3D Fluorescent Images
Confocal fluorescent microscopy is a major tool to investigate the molecular orchestration of biomedical samples. The quality of the image acquisition depends critically on the tissue quality and thickness, the type, and concentration of antibodies used, as well as on microscope parameters. Due to these factors, intra-sample and inter-sample variability inevitably arises. Segmentation and quantification of targeted proteins can thus become a challenging process. Image processing techniques need therefore to address the acquisitions variability to minimize the risk of biases originating from changes in signal intensity, background noise, and parameterization. Here, we introduce PaFSe, a parameter-free segmentation algorithm for 3D fluorescent images. The algorithm is based on our established PRAQA approach, which evaluates the dispersion of several pixel intensity neighborhoods allowing for a statistical assessment whether individual subfields of an image can be considered as positive signal or background. PaFSe extends PRAQA by a fully automatic estimate for the segmentation parameters, and thereby provides a completely parameter-free and robust segmentation algorithm. By comparing PaFSe with Ilastik on synthetic examples, we show that our method achieves similar performances as a supervised approach in low-to-moderate noise environments without the need of tedious training. Furthermore, we validate the efficiency of PaFSe by segmenting and quantifying the abundance of hyperphosphorylated Tau protein in post-mortem human brain samples from Alzheimer’s disease patients and age-matched controls, where we obtain quantification values highly correlated with manual neuropathological segmentation. PaFSe is a parameter-free, fast, and adaptive approach for robust segmentation and quantification of protein abundance from complex 3D fluorescent images and is freely available at https://doi.org/10.17881/j20h-pa27.
- Open Access
Concomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
Hippocampal alteration is at the centre of memory decline in the most common age-related neurodegenerative diseases: Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB). However, the subregional deterioration of the hippocampus differs between both diseases with more severe atrophy in the CA1 subfield of the AD patients. How AD and DLB-typical pathologies compose the various local microenvironment of the hippocampus across AD and DLB needs to be further explored to understand this process. Additionally, microglia responses could further impact the atrophy rate. Some studies suggest that microglia react differently according to the underlying neurodegenerative disorder. How microglia are transformed across hippocampal subfields in AD and DLB, and how their changes are associated with disease-typical pathologies remains to be determined. To these purposes, we performed a volumetric analysis of phospho-Tau (P-Tau), Amyloid-ß (Aß), and phospho-α-Synuclein (P-Syn) loads, quantified and classified microglia according to distinct morphological phenotypes using high-resolution confocal 3D microscopy of hippocampal CA1, CA3 and DG/CA4 subfields of late-onset AD (n=10) and DLB (n=8) as well as age-matched control samples (n=11). We found that each of the Tau, Aß and Synuclein pathologies followed a specific subregional distribution, relatively preserved across AD and DLB. P-Tau, Aß and P-Syn burdens were significantly exacerbated in AD, with Tau pathology being particularly severe in the AD CA1. P-Tau and P-Syn burdens were highly correlated across subfields and conditions (R2Spear = 0.79; P < 0.001) and result from a local co-distribution of P-Tau and P-Syn inclusions in neighbouring neurons, with only a low proportion of double-positive cells. In parallel, we assessed the changes of the microglia responses by measuring 16 morphological features of more than 35,000 individual microglial cells and classifying them into seven-distinct morphological clusters. We found microglia features- and clusters-variations subfield- and condition-dependent. Two of the seven morphological clusters, with more amoeboid and less branched forms, were identified as disease-enriched and found to be further increased in AD. Interestingly, some microglial features or clusters were associated with one but more often with a combination of two pathologies in a subfield-dependent manner. In conclusion, our study shows a multimodal association of the hippocampal microglia responses with the co-occurrence, distribution and severity of AD and DLB pathologies. In DLB hippocampi, pathological imprint and microglia responses follow AD trends but with lesser severity. Our study suggests that the increased pathological burdens of P-Tau and P-Syn and associated microglia alterations are involved in a more severe deterioration of the CA1 in AD as compared to DLB.
Open AccessConcomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
Hippocampal alteration is at the centre of memory decline in the most common age-related neurodegenerative diseases: Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB). However, the subregional deterioration of the hippocampus differs between both diseases with more severe atrophy in the CA1 subfield of the AD patients. How AD and DLB-typical pathologies compose the various local microenvironment of the hippocampus across AD and DLB needs to be further explored to understand this process. Additionally, microglia responses could further impact the atrophy rate. Some studies suggest that microglia react differently according to the underlying neurodegenerative disorder. How microglia are transformed across hippocampal subfields in AD and DLB, and how their changes are associated with disease-typical pathologies remains to be determined. To these purposes, we performed a volumetric analysis of phospho-Tau (P-Tau), Amyloid-ß (Aß), and phospho-α-Synuclein (P-Syn) loads, quantified and classified microglia according to distinct morphological phenotypes using high-resolution confocal 3D microscopy of hippocampal CA1, CA3 and DG/CA4 subfields of late-onset AD (n=10) and DLB (n=8) as well as age-matched control samples (n=11). We found that each of the Tau, Aß and Synuclein pathologies followed a specific subregional distribution, relatively preserved across AD and DLB. P-Tau, Aß and P-Syn burdens were significantly exacerbated in AD, with Tau pathology being particularly severe in the AD CA1. P-Tau and P-Syn burdens were highly correlated across subfields and conditions (R2Spear = 0.79; P < 0.001) and result from a local co-distribution of P-Tau and P-Syn inclusions in neighbouring neurons, with only a low proportion of double-positive cells. In parallel, we assessed the changes of the microglia responses by measuring 16 morphological features of more than 35,000 individual microglial cells and classifying them into seven-distinct morphological clusters. We found microglia features- and clusters-variations subfield- and condition-dependent. Two of the seven morphological clusters, with more amoeboid and less branched forms, were identified as disease-enriched and found to be further increased in AD. Interestingly, some microglial features or clusters were associated with one but more often with a combination of two pathologies in a subfield-dependent manner. In conclusion, our study shows a multimodal association of the hippocampal microglia responses with the co-occurrence, distribution and severity of AD and DLB pathologies. In DLB hippocampi, pathological imprint and microglia responses follow AD trends but with lesser severity. Our study suggests that the increased pathological burdens of P-Tau and P-Syn and associated microglia alterations are involved in a more severe deterioration of the CA1 in AD as compared to DLB.